TIDMAATG 
 

Albion Technology & General VCT PLC

Interim Management Statement

LEI code: 213800TKJUY376H3KN16

Introduction

I present Albion Technology & General VCT PLC (the "Company")'s interim management statement for the period from 1 January 2023 to 31 March 2023.

Performance

The Company's unaudited net asset value (NAV) as at 31 March 2023 was GBP140.4 million or 78.59 pence per share (excluding treasury shares), an increase of 5.67 pence per share (7.8%) since 31 December 2022.

On 2 March 2023, a NAV update was announced, following Quantexa undergoing an external fundraising process at a significantly higher valuation than was included in the Company's NAV. This external fundraising round has now completed and was announced by Quantexa on 4 April 2023, raising $129 million. The NAV at 31 March 2023 has increased by 1.04 pence per share (1.34%) compared to the 2 March 2023 NAV update.

Albion VCTs' Top Up Offers

A prospectus Top Up Offer of new Ordinary shares was launched on 10 October 2022. The Board announced on 18 January 2023 that, following strong demand for the Company's shares, it had elected to exercise its over-allotment facility, taking the total Offer to GBP15.5 million. The Offer was fully subscribed and closed to further applications on 22 March 2023.

During the period from 1 January 2023 to 31 March 2023, the Company issued the following shares under the Albion VCTs' Top Up Offers:

 
                 Number of shares      Issue price per      Net consideration 
Date                  issued                share           received GBP'000 
--------------  -------------------  --------------------  ------------------- 
31 March 2023            12,395,704           79.60 pence                9,621 
--------------  -------------------  --------------------  ------------------- 
 

Portfolio

The following investments have been made during the period from 1 January 2023 to 31 March 2023:

 
Further 
investments    GBP'000                         Activity 
-------------  -------  ------------------------------------------------------ 
Proveca          254           Reformulation of medicines for children 
-------------  -------  ------------------------------------------------------ 
Seldon                  Enabling enterprises to deploy Machine Learning models 
Technologies     103                         in production 
-------------  -------  ------------------------------------------------------ 
Brytlyt          19                A GPU database software provider 
-------------  -------  ------------------------------------------------------ 
                          A designer and manufacturer of radiation detection 
Symetrica        12                            equipment 
-------------  -------  ------------------------------------------------------ 
Total further 
 investments       799 
-------------  ------- 
 

Top ten holdings as at 31 March 2023:

 
                                      % of 
                                       net 
                      Carrying value  asset 
Investment                GBP'000     value                            Activity 
--------------------  --------------  -----  ------------------------------------------------------------ 
Quantexa                  28,341      20.6       Network analytics platform to detect financial crime 
--------------------  --------------  -----  ------------------------------------------------------------ 
Radnor House School 
(TopCo)                   6,043        4.4            Independent school for children aged 2-18 
--------------------  --------------  -----  ------------------------------------------------------------ 
Proveca                        5,099    3.7                       Reformulation of medicines for children 
--------------------  --------------  -----  ------------------------------------------------------------ 
Chonais River Hydro       4,403        3.2   Owner and operator of a 2 MW hydro-power scheme in 
                                              the Scottish Highlands 
--------------------  --------------  -----  ------------------------------------------------------------ 
Oviva                     4,082        3.0   A technology enabled service business in medical nutritional 
                                              therapy (MNT) 
--------------------  --------------  -----  ------------------------------------------------------------ 
The Evewell Group         3,498        2.5   Operator of women's health centres focusing on fertility 
--------------------  --------------  -----  ------------------------------------------------------------ 
Cantab Research (T/A      3,411        2.5   Provider of low footprint automated speech recognition 
 Speechmatics)                                which can be deployed in the cloud, on premise or 
                                              on device 
--------------------  --------------  -----  ------------------------------------------------------------ 
Egress Software           2,899        2.1   Encrypted email & file transfer service provider 
 Technologies 
--------------------  --------------  -----  ------------------------------------------------------------ 
Runa Network              2,692        2.0   Cloud platform and infrastructure that enables corporates 
 (previously                                  to issue digital incentives and payouts 
 WeGift) 
--------------------  --------------  -----  ------------------------------------------------------------ 
Gharagain River           2,570        1.9   Owner and operator of a 1 MW hydro-power scheme in 
 Hydro                                        the Scottish Highlands 
--------------------  --------------  -----  ------------------------------------------------------------ 
 

A full breakdown of the Company's portfolio can be found on the Company's webpage on the Manager's website at www.albion.capital/funds/AATG.

Share buy-backs

During the period from 1 January 2023 to 31 March 2023, the Company did not buy back any shares.

It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board's intention for buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.

Board composition

I am retiring from the Board today following the Annual General Meeting, having served as a Director of the Company for nine years, with my first seven years as Chairman of the Audit & Risk Committee and the last two years as Chairman of the Company. Clive Richardson, who has been on the Board since 1 June 2022, will succeed me as Chairman of the Board.

I would like to take this opportunity to thank all my existing and former board colleagues and our Manager, Albion Capital, for their contributions to the Company towards the progress made in the last nine years by the Company.

The Board continues to have a well experienced complement of Directors and is well advanced in succession planning. I wish the Company, and those associated with it, well in the future.

Material events and transactions after the period end

After the period end, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs' Prospectus Top Up Offers 2022/23:

 
                 Number of shares      Issue price per      Net consideration 
Date                  issued                share           received GBP'000 
--------------  -------------------  --------------------  ------------------- 
14 April 2023               558,086  78.80 to 79.60 pence                  433 
--------------  -------------------  --------------------  ------------------- 
 

There have been no other material events or transactions after the period end to the date of this announcement.

Further information

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company's webpage on the Manager's website at www.albion.capital/funds/AATG.

Robin Archibald, Chairman

6 June 2023

For further information please contact:

Vikash Hansrani

Operations Partner

Albion Capital Group LLP

Telephone: 020 7601 1850

 
 

(END) Dow Jones Newswires

June 06, 2023 06:34 ET (10:34 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Albion Technology & Gene... (LSE:AATG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Albion Technology & Gene....
Albion Technology & Gene... (LSE:AATG)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Albion Technology & Gene....